InvestorsHub Logo
Followers 71
Posts 7713
Boards Moderated 0
Alias Born 09/28/2012

Re: None

Monday, 07/20/2020 6:29:31 PM

Monday, July 20, 2020 6:29:31 PM

Post# of 232893
Normally I’d sell here knowing the M2M won’t be significant BUT the FDA has nothing in the quiver. So anything is better than Remdesidie at this point and the FDA should recognize. If Remdesidie is approved as the SOC then a marginal LL on M2M should be the GSOC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News